XML 24 R46.htm IDEA: XBRL DOCUMENT v2.4.1.9
Investment in Affiliate (Details 1) (NeutriSci [Member], USD $)
9 Months Ended 12 Months Ended
Dec. 28, 2013
Jan. 03, 2015
Dec. 29, 2012
NeutriSci [Member]
     
Carrying value, equity investment, beginning balance $ 2,157,804us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cdxc_NeutriSciMember
$ 1,887,844us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cdxc_NeutriSciMember
$ 2,157,804us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cdxc_NeutriSciMember
Company's share of NeutriSci's loss during period (44,961)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cdxc_NeutriSciMember
(21,543)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cdxc_NeutriSciMember
 
Proceeds from assignment of the Senior Note   (1,092,500)us-gaap_ProceedsFromIssuanceOfMediumTermNotes
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cdxc_NeutriSciMember
 
Proceeds from sale and transfer of the Preferred Shares   (749,515)us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cdxc_NeutriSciMember
 
Proceeds (loss) from investment in affiliate (225,000)us-gaap_ProceedsFromNotesPayable
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cdxc_NeutriSciMember
(24,286)us-gaap_ProceedsFromNotesPayable
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cdxc_NeutriSciMember
 
Carrying value, equity investment, ending balance $ 1,887,844us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cdxc_NeutriSciMember
   $ 2,157,804us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cdxc_NeutriSciMember
Changes in Carrying Value and Ownership Percentage for ChromaDex Corporation      
Ownership percentage, beginning of period 5.70%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cdxc_NeutriSciMember
4.90%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cdxc_NeutriSciMember
 
Ownership percentage, end of period 4.90%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cdxc_NeutriSciMember
0.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= cdxc_NeutriSciMember